论文信息 - Oral ketamine: a promising treatment for restless legs syndrome.

Oral ketamine: a promising treatment for restless legs syndrome.

IMPLICATIONS Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome. A mechanism for the efficacy of this treatment is discussed.

N. Kapur | R. Friedman

[1] R. Yezierski,et al. The role of neuroinflammation and neuroimmune activation in persistent pain , 2001, Pain.

[2] J. Raeder,et al. Ketamine: a new look at an old drug. , 2000, Current opinion in anaesthesiology.

[3] J. Weinstein,et al. Spinal glial activation and cytokine expression after lumbar root injury in the rat. , 2000, Spine.

[4] K. Plaschke,et al. Ketamine Modulates the Stimulated Adhesion Molecule Expression on Human Neutrophils In Vitro , 2000, Anesthesia and analgesia.

[5] A. Shigematsu,et al. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro , 1999 .

[6] H. Hays,et al. Clinical experience with oral ketamine. , 1999, Journal of pain and symptom management.

[7] M. Durieux,et al. Ketamine: Teaching an Old Drug New Tricks , 1998, Anesthesia and analgesia.

[8] M. Frass,et al. Ketamine significantly reduces the migration of leukocytes through endothelial cell monolayers. , 1998, Critical care medicine.

[9] M. Silber. Restless legs syndrome. , 1997, Mayo Clinic proceedings.

[10] S. O’Keeffe. Restless legs syndrome. A review. , 1996, Archives of internal medicine.